Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Falling Comet
900.7000 5.65 (0.63%)
NSE Jan 13, 2026 15:31 PM
Volume: 494.0K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
900.70
0.63%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading below all available SMAs
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch | 13 Jan 2026, 04:07PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020